Lineage Cell Therapeutics Statistics
Total Valuation
LCTX has a market cap or net worth of $105.73 million. The enterprise value is $60.07 million.
Important Dates
The last earnings date was Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LCTX has 228.36 million shares outstanding. The number of shares has increased by 19.97% in one year.
| Current Share Class | 228.36M |
| Shares Outstanding | 228.36M |
| Shares Change (YoY) | +19.97% |
| Shares Change (QoQ) | -5.89% |
| Owned by Insiders (%) | 0.42% |
| Owned by Institutions (%) | 26.69% |
| Float | 177.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.22 |
| Forward PS | 7.90 |
| PB Ratio | 1.34 |
| P/TBV Ratio | 4.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.82, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.82 |
| Quick Ratio | 3.68 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -21.75% and return on invested capital (ROIC) is -17.29%.
| Return on Equity (ROE) | -21.75% |
| Return on Assets (ROA) | -12.10% |
| Return on Invested Capital (ROIC) | -17.29% |
| Return on Capital Employed (ROCE) | -21.61% |
| Revenue Per Employee | $124,117 |
| Profits Per Employee | -$210,468 |
| Employee Count | 77 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.52% in the last 52 weeks. The beta is 1.42, so LCTX's price volatility has been higher than the market average.
| Beta (5Y) | 1.42 |
| 52-Week Price Change | -57.52% |
| 50-Day Moving Average | 0.47 |
| 200-Day Moving Average | 0.68 |
| Relative Strength Index (RSI) | 49.57 |
| Average Volume (20 Days) | 895,663 |
Short Selling Information
The latest short interest is 30.00 million, so 13.14% of the outstanding shares have been sold short.
| Short Interest | 30.00M |
| Short Previous Month | 26.64M |
| Short % of Shares Out | 13.14% |
| Short % of Float | 16.88% |
| Short Ratio (days to cover) | 23.99 |
Income Statement
In the last 12 months, LCTX had revenue of $9.56 million and -$16.21 million in losses. Loss per share was -$0.08.
| Revenue | 9.56M |
| Gross Profit | -3.27M |
| Operating Income | -21.32M |
| Pretax Income | -24.19M |
| Net Income | -16.21M |
| EBITDA | -20.72M |
| EBIT | -21.32M |
| Loss Per Share | -$0.08 |
Full Income StatementBalance Sheet
The company has $47.91 million in cash and $2.24 million in debt, giving a net cash position of $45.66 million or $0.20 per share.
| Cash & Cash Equivalents | 47.91M |
| Total Debt | 2.24M |
| Net Cash | 45.66M |
| Net Cash Per Share | $0.20 |
| Equity (Book Value) | 77.66M |
| Book Value Per Share | 0.35 |
| Working Capital | 36.90M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$22.20 million and capital expenditures -$624,000, giving a free cash flow of -$22.82 million.
| Operating Cash Flow | -22.20M |
| Capital Expenditures | -624,000 |
| Free Cash Flow | -22.82M |
| FCF Per Share | -$0.10 |
Full Cash Flow StatementMargins
Gross margin is -34.17%, with operating and profit margins of -223.10% and -169.57%.
| Gross Margin | -34.17% |
| Operating Margin | -223.10% |
| Pretax Margin | -169.16% |
| Profit Margin | -169.57% |
| EBITDA Margin | -216.85% |
| EBIT Margin | -223.10% |
| FCF Margin | n/a |
Dividends & Yields
LCTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.97% |
| Shareholder Yield | -19.97% |
| Earnings Yield | -15.33% |
| FCF Yield | -21.58% |
Dividend DetailsAnalyst Forecast
The average price target for LCTX is $4.20, which is 807.13% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.20 |
| Price Target Difference | 807.13% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 59.14% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on October 31, 1997. It was a forward split with a ratio of 3:1.
| Last Split Date | Oct 31, 1997 |
| Split Type | Forward |
| Split Ratio | 3:1 |
Scores
LCTX has an Altman Z-Score of -2.34 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.34 |
| Piotroski F-Score | 3 |